Tags

Type your tag names separated by a space and hit enter

[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
MMW Munch Med Wochenschr. 1977 Jul 01; 119(26):901-4.MM

Abstract

The preparation Trental 100 was given to 73 patients in a vascular surgery department at a daily dose of 2-3 dragees over an average of 2-3 months. 51 of 67 patients with chronic arterial disorders of the lower extremities and 5 of 6 patients with circulatory disturbances in the brachial region improved, as measured by the walking distance, reactive hyperemia time, pain at rest and effect in tissue defects. Tests for objective tolerance showed no effects on the blood picture, liver and kidney functions and carbohydrate metabolism. In a few patients, subjective intolerance disappeared after reducing the dose.

Authors

von Westphalen JG
No affiliation info available

MeSH

AdultAgedArterial Occlusive DiseasesBloodClinical Trials as TopicFemaleGaitHemodynamicsHumansHyperemiaMaleMiddle AgedPentoxifyllineTheobromine

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

ger

PubMed ID

408616

Citation

von Westphalen, J G.. "[Clinical Trial of Trental 100 in Patients With Peripheral Arterial Occlusive Diseases (author's Transl)]." MMW, Munchener Medizinische Wochenschrift, vol. 119, no. 26, 1977, pp. 901-4.
von Westphalen JG. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. MMW Munch Med Wochenschr. 1977;119(26):901-4.
von Westphalen, J. G. (1977). [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. MMW, Munchener Medizinische Wochenschrift, 119(26), 901-4.
von Westphalen JG. [Clinical Trial of Trental 100 in Patients With Peripheral Arterial Occlusive Diseases (author's Transl)]. MMW Munch Med Wochenschr. 1977 Jul 1;119(26):901-4. PubMed PMID: 408616.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. A1 - von Westphalen,J G, PY - 1977/7/1/pubmed PY - 1977/7/1/medline PY - 1977/7/1/entrez SP - 901 EP - 4 JF - MMW, Munchener medizinische Wochenschrift JO - MMW Munch Med Wochenschr VL - 119 IS - 26 N2 - The preparation Trental 100 was given to 73 patients in a vascular surgery department at a daily dose of 2-3 dragees over an average of 2-3 months. 51 of 67 patients with chronic arterial disorders of the lower extremities and 5 of 6 patients with circulatory disturbances in the brachial region improved, as measured by the walking distance, reactive hyperemia time, pain at rest and effect in tissue defects. Tests for objective tolerance showed no effects on the blood picture, liver and kidney functions and carbohydrate metabolism. In a few patients, subjective intolerance disappeared after reducing the dose. SN - 0341-3098 UR - https://www.unboundmedicine.com/medline/citation/408616/[Clinical_trial_of_Trental_100_in_patients_with_peripheral_arterial_occlusive_diseases__author's_transl_]_ DB - PRIME DP - Unbound Medicine ER -